Robust CRISPR-Cas9 Genetic Editing of Primary Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma Cells

Hemasphere. 2023 Jun 7;7(6):e909. doi: 10.1097/HS9.0000000000000909. eCollection 2023 Jun.

Judith Mateos-Jaimez¹, Maurizio Mangolini², Anna Vidal¹, Marta Kulis¹, Dolors Colomer^{1

3

4

5}, Elias Campo^{1

3

4

5}, Ingo Ringshausen², Jose I Martin-Subero^{1

3

6}, Alba Maiques-Diaz¹

¹ Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
² Department of Hematology and Cambridge Stem Cell Institute, University of Cambridge, United Kingdom.
³ Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.
⁴ Hematopathology Unit, Pathology Department, Hospital Clinic, Barcelona, Spain.
⁵ University of Barcelona, Spain.
⁶ Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.

No abstract available

Grants and funding